Search
for
Sort by
Research 61–90 of 139
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Ophthalmologic Comorbidities in Alopecia Areata
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- A perspective on predictive markers of alopecia
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- MHC Class I-Like MILL Molecules Are β2-Microglobulin-Associated, GPI-Anchored Glycoproteins That Do Not Require TAP for Cell Surface Expression
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Alopecia Areata Incognita: Current Evidence
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Entdeckung von Autoantigenen bei der Haarverluststörung Alopecia areata: Implikation von posttranslationalen Modifikationen
- ULBP3: a marker for alopecia areata incognita
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Treatment of alopecia areata: “What is new on the horizon?”
- Evaluation of Serum UL16 Binding Protein 3 in Patients with Tinea capitis
- 616 Endoplasmic reticulum stress upregulates NKG2D ligands in the hair follicle
- Selling stem cells in Australia: assessing the impact of new advertising standards on business practices
- Autologous stem cell-based interventions in Australia: exploring patient experience in light of regulatory exceptionalism
- Alopecia Areata